Investigating anti-D in an individual with the weak D type 2 genotype
, , , , , und
22. Sept. 2022
Über diesen Artikel
Online veröffentlicht: 22. Sept. 2022
Seitenbereich: 77 - 81
DOI: https://doi.org/10.21307/immunohematology-2022-046
Schlüsselwörter
© 2022 S. Phou et al., published by Sciendo
Phou, S.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Nguyen, N.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Revilla, J.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Rodberg, K.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Gibb, D.R.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Pepkowitz, S.H.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Klapper, E.B.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States